Letters
Travel prophylaxis
BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6976.401c (Published 11 February 1995) Cite this as: BMJ 1995;310:401Figures in study were incorrect
- E Walker*
- Director Travel Advisory Service, Scottish Centre for Infection and Environmental Health, Ruchill Hospital, Glasgow G20 9NB
EDITOR,—Debate about the role of immunoprophylaxis for travellers is to be encouraged, but health care planners should not be lulled into complacency by R H Behrens and J A Roberts's conclusion that vaccination against typhoid and hepatitis A is not cost effective for society or the person concerned.1 No such study should group all countries outside Europe, North America, and Australasia into the same category of risk regardless of the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.